Michael Benedict Yamoah | Access to Medicine

Michael Benedict Yamoah is a member of the 2026 Expert Review Committee for the Access to Medicine Index. Michael is a Director with Equity Ownership Services (EOS) at Federated Hermes, primarily covering engagement in North America with additional exposure to Europe and Africa. He currently co-leads EOS’s strategic engagements across the healthcare and pharmaceutical industries, addressing critical investor concerns related to access to healthcare and medicine, human capital management, AI and data privacy, and antimicrobial resistance.

Michael previously worked as a senior sustainability consultant and US climate strategy lead for Quantis International – now part of Boston Consulting Group. He has held various corporate roles, including acting climate and sustainability research lead at Aramco (US); sustainability and analytics manager at Bechtel Corporation; consultant to the World Bank Group and the Asian Development Bank; as well as international climate programme support at the Natural Resources Defense Council (NRDC).

Michael holds multiple advanced degrees, including a Master of Business Administration from NYU Stern, a Master of Arts in International Economic Development from George Washington University and a graduate certificate in Data Science from Georgetown University. He is currently pursuing a Master of Legal Studies at UCLA Law and a PhD at University College London.